Evidence map›Paper›PMID 36153351›Full record

ArticleNPJ Parkinson's disease2022

Axial impairment and falls in Parkinson's disease: 15 years of subthalamic deep brain stimulation.

Alessandro Zampogna, Francesco Cavallieri, Francesco Bove, Antonio Suppa, Anna Castrioto, Sara Meoni, Pierre Pélissier, Emmanuelle Schmitt, Amélie Bichon, Eugénie Lhommée and 5 more

Open access · goldAbstract read
In one paragraph

Article in NPJ Parkinson's disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Towards the Prevention of Freezing of Gait in Parkinson's Disease.The European journal of neuroscience · 2026
    Review
  4. What's in a name? reframing advanced Parkinson's disease as a multidimensional state.Journal of neural transmission (Vienna, Austria : 1996) · 2026
    Review
  5. Article
  6. Clinical Utility ofGenes · 2026
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Alessandro ZampognaDivision of Neurology, Grenoble Alpes University, CHU of Grenoble, Grenoble Institute of Neurosciences, Inserm U1216, Grenoble, France.ORCID http://orcid.org/0000-0002-0227-1993
Francesco CavallieriNeurology Unit, Neuromotor and Rehabilitation Department, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Francesco BoveNeurology Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.ORCID http://orcid.org/0000-0002-2959-6659
Antonio SuppaDepartment of Human Neurosciences, Sapienza University of Rome, Rome, Italy.
Anna CastriotoDivision of Neurology, Grenoble Alpes University, CHU of Grenoble, Grenoble Institute of Neurosciences, Inserm U1216, Grenoble, France.ORCID http://orcid.org/0000-0002-2385-7096
Sara MeoniDivision of Neurology, Grenoble Alpes University, CHU of Grenoble, Grenoble Institute of Neurosciences, Inserm U1216, Grenoble, France.ORCID http://orcid.org/0000-0003-2995-6762
Pierre PélissierDivision of Neurology, Grenoble Alpes University, CHU of Grenoble, Grenoble Institute of Neurosciences, Inserm U1216, Grenoble, France.
Emmanuelle SchmittDivision of Neurology, Grenoble Alpes University, CHU of Grenoble, Grenoble Institute of Neurosciences, Inserm U1216, Grenoble, France.ORCID http://orcid.org/0000-0002-9044-6131
Amélie BichonDivision of Neurology, Grenoble Alpes University, CHU of Grenoble, Grenoble Institute of Neurosciences, Inserm U1216, Grenoble, France.
Eugénie LhomméeDivision of Neurology, Grenoble Alpes University, CHU of Grenoble, Grenoble Institute of Neurosciences, Inserm U1216, Grenoble, France.
Andrea KistnerDivision of Neurology, Grenoble Alpes University, CHU of Grenoble, Grenoble Institute of Neurosciences, Inserm U1216, Grenoble, France.
Stephan ChabardèsDivision of Neurosurgery, CHU of Grenoble, Grenoble Alpes University, Grenoble, France.
Eric SeigneuretDivision of Neurosurgery, CHU of Grenoble, Grenoble Alpes University, Grenoble, France.
Valerie FraixDivision of Neurology, Grenoble Alpes University, CHU of Grenoble, Grenoble Institute of Neurosciences, Inserm U1216, Grenoble, France.ORCID http://orcid.org/0000-0003-4473-9993
Elena MoroDivision of Neurology, Grenoble Alpes University, CHU of Grenoble, Grenoble Institute of Neurosciences, Inserm U1216, Grenoble, France. emoro@chu-grenoble.fr.ORCID http://orcid.org/0000-0002-7968-5908
Inserm · FRCentre Hospitalier Universitaire de Grenoble · FRAgostino Gemelli University Polyclinic · ITIstituto Neurologico Mediterraneo · ITUniversity of Modena and Reggio Emilia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this retrospective study, we longitudinally analyzed axial impairment and falls in people with Parkinson's disease (PD) and subthalamic nucleus deep brain stimulation (STN-DBS). Axial scores and falling frequency were examined at baseline, and 1, 10, and 15 years after surgery. Preoperative demographic and clinical data, including PD duration and severity, phenotype, motor and cognitive scales, medications, and vascular changes on neuroimaging were examined as possible risk factors through Kaplan-Meier and Cox regression analyses. Of 302 individuals examined before and at 1 year after surgery, 102 and 57 were available also at 10 and 15 years of follow-up, respectively. Axial scores were similar at baseline and at 1 year but worsened at 10 and 15 years. The prevalence rate of frequent fallers progressively increased from baseline to 15 years. Preoperative axial scores, frontal dysfunction and age at PD onset were risk factors for axial impairment progression after surgery. Axial scores, akinetic/rigid phenotype, age at disease onset and disease duration at surgery predicted frequent falls. Overall, axial signs progressively worsened over the long-term period following STN-DBS, likely related to the progression of PD, especially in a subgroup of subjects with specific risk factors.

Identifiers

PMID36153351
PMCPMC9509398
OpenAlexW4296977032

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.